The clinical role of CX3CL1-CX3CR1 signaling has been reported to be contradictory and it may exert both pro-tumor and anti-tumor effects based on tumor tissue and histological grade of tumor38,39. This evidence concerns the gene CX3CL1 and neoplasm.